Krystexxa (PEGLOTICASE)
Ended Awarded Last action
- Contract number
- 36C26024F0051
- Awardee
-
Horizon Therapeutics Usa, Inc. UEI SK1UK7S74GB3
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $0
Award facts
- Contract value
- $0.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- La Vergne, TN 37086, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$467,254 | |
| Original award | $467,254 |
About this award
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 awarded Horizon Therapeutics USA Inc. a $467,253.54 firm fixed price delivery order against the company's Pharmaceuticals and Drugs schedule contract. The order is for the drug KRYSTEXXA, or pegloticase, to treat gout for the period of December 23, 2023 through December 22, 2024. Place of performance will be Horizon's facility in La Vergne, Tennessee. The funding supports the VA's mission to provide quality healthcare to eligible veterans through its integrated network of medical centers and clinics. No subcontractors or set-aside designations were indicated in the award information.
Quick answers
Who was awarded contract 36C26024F0051?
36C26024F0051 was awarded to Horizon Therapeutics Usa, Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on December 23, 2023.
How much is contract 36C26024F0051 worth?
The government has obligated $0 on 36C26024F0051.
Is contract 36C26024F0051 an order under another contract?
Yes. 36C26024F0051 is a delivery order under 36F79719D0224, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26024F0051 competed?
The extent of competition for 36C26024F0051 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award